According to filings with the U.S. Securities and Exchange Commission, Neurona Therapeutics is raising up to $119,999,974.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Cory Nicholas played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Neurona Therapeutics
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the companys scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.

To learn more about Neurona Therapeutics, visit http://www.neuronatherapeutics.com/

Contact:
Cory Nicholas, Chief Executive Officer
650-799-6465
https://www.linkedin.com/in/cory-r-nicholas-phd-a78a6a23/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.